Daniel G.  Kaye net worth and biography

Daniel Kaye Biography and Net Worth

Director of Equitable

Mr. Kaye has been a director since April 2018. From January 2013 to May 2014, Mr. Kaye served as Interim Chief Financial Officer and Treasurer of HealthEast Care System (“HealthEast”). Prior to joining HealthEast, Mr. Kaye spent 35 years with Ernst & Young LLP (“Ernst & Young”) from which he retired in 2012. Throughout his time at Ernst & Young, where he was an audit partner for 25 years, Mr. Kaye enjoyed a track record of increasing leadership and responsibilities, including serving as the New England Managing Partner and the Midwest Managing Partner of Assurance. Mr. Kaye was a member of the Board of Directors of Ferrellgas Partners L.P. (“Ferrellgas”) from August 2012 to November 2015 where he served on the Audit Committee and Corporate Governance and Nominating Committee (Chair). Mr. Kaye is a Certified Public Accountant and National Association of Corporate Directors (NACD) Board Leadership Fellow. Mr. Kaye is also a director of Equitable and Equitable America since September 2015, AllianceBernstein Corporation since May 2017 and CME Group, Inc. since May 2019. Mr. Kaye currently serves as the Chairman of the Audit Committee of CME Group, Inc.

Mr. Kaye brings to the Board invaluable expertise as an audit committee financial expert, and extensive financial services and insurance industry experience and his general knowledge and experience in financial matters developed through his roles at Ernst & Young and HealthEast. The Board also benefits from his experience as a director of Ferrellgas, AllianceBernstein Corporation and CME Group, Inc.

What is Daniel G. Kaye's net worth?

The estimated net worth of Daniel G. Kaye is at least $2.19 million as of December 20th, 2023. Mr. Kaye owns 53,757 shares of Equitable stock worth more than $2,189,523 as of May 29th. This net worth approximation does not reflect any other assets that Mr. Kaye may own. Learn More about Daniel G. Kaye's net worth.

How do I contact Daniel G. Kaye?

The corporate mailing address for Mr. Kaye and other Equitable executives is 1290 AVENUE OF THE AMERICAS, NEW YORK NY, 10104. Equitable can also be reached via phone at (212) 554-1234 and via email at [email protected]. Learn More on Daniel G. Kaye's contact information.

Has Daniel G. Kaye been buying or selling shares of Equitable?

Daniel G. Kaye has not been actively trading shares of Equitable during the past quarter. Most recently, Daniel G. Kaye sold 4,845 shares of the business's stock in a transaction on Wednesday, December 20th. The shares were sold at an average price of $33.85, for a transaction totalling $164,003.25. Following the completion of the sale, the director now directly owns 53,757 shares of the company's stock, valued at $1,819,674.45. Learn More on Daniel G. Kaye's trading history.

Who are Equitable's active insiders?

Equitable's insider roster includes William Eckert, IV (CAO), Dave Hattem (EVP), Jeffrey Hurd (COO), Daniel Kaye (Director), Nick Lane (Insider), Anders Malmstrom (CFO), Kristi Matus (Director), Mark Pearson (CEO), Robin Raju (CFO), Bertram Scott (Director), and Charles Stonehill (Director). Learn More on Equitable's active insiders.

Are insiders buying or selling shares of Equitable?

During the last year, insiders at the sold shares 16 times. They sold a total of 486,225 shares worth more than $17,188,004.59. The most recent insider tranaction occured on May, 2nd when insider Seth P Bernstein sold 152,473 shares worth more than $5,803,122.38. Insiders at Equitable own 1.1% of the company. Learn More about insider trades at Equitable.

Information on this page was last updated on 5/2/2024.

Daniel G. Kaye Insider Trading History at Equitable

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/20/2023Sell4,845$33.85$164,003.2553,757View SEC Filing Icon  
3/11/2020Buy3,000$15.74$47,220.0021,474View SEC Filing Icon  
See Full Table

Daniel G. Kaye Buying and Selling Activity at Equitable

This chart shows Daniel G Kaye's buying and selling at Equitable by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Equitable Company Overview

Equitable logo
Equitable Holdings, Inc., together with its consolidated subsidiaries, operates as a diversified financial services company worldwide. The company operates through six segments: Individual Retirement, Group Retirement, Investment Management and Research, Protection Solutions, Wealth Management, and Legacy. The Individual Retirement segment offers a suite of variable annuity products primarily to affluent and high net worth individuals. The Group Retirement segment provides tax-deferred investment and retirement services or products to plans sponsored by educational entities, municipalities, and not-for-profit entities, as well as small and medium-sized businesses. The Investment Management and Research segment offers diversified investment management, research, and related services to various clients through institutional. The Protection Solutions segment provides life insurance products, such as VUL insurance and IUL insurance, term life, and employee benefits business, such as dental, vision, life, as well as short- and long-term disability insurance products to small and medium-sized businesses. The Wealth Management segment offers discretionary and non-discretionary investment advisory accounts, financial planning and advice, life insurance, and annuity products. The Legacy segment consists of the capital intensive fixed-rate GMxB business that includes ROP death benefits. The company was formerly known as AXA Equitable Holdings, Inc. and changed its name to Equitable Holdings, Inc. in January 2020. Equitable Holdings, Inc. was founded in 1859 and is based in New York, New York.
Read More

Today's Range

Now: $40.73
Low: $39.87
High: $40.86

50 Day Range

MA: $38.34
Low: $35.63
High: $40.99

2 Week Range

Now: $40.73
Low: $24.23
High: $41.26

Volume

3,733,827 shs

Average Volume

2,646,289 shs

Market Capitalization

$13.25 billion

P/E Ratio

12.61

Dividend Yield

2.15%

Beta

1.4